Does HIV disease continues despite antiviral responses and antiretroviral therapy?
Combination antiretroviral therapy to treat human immunodeficiency
virus (HIV)this disease has proven
successful for those who can
access and afford it – yet HIV disease persists indefinitely in a reservoir of
cells, despite efficient and despite host antiviral immune responses. An HIV
cure is accordinglythe next aspirational goal and challenge, though approaches
different in their objectives with
‘functional cures’ aiming for durable viral control in the absence of ART, and
‘sterilizing cures’ aiming for the more difficult to realize objective of
finalize viral eradication.
Viral persistence through anatomical sequestration virus
Anatomical sequestration of reservoir-harboring cells poses
additional challenges to curative interfrence
strategies, by limiting access to, and function of, immune effectors.
incresingly, a new study from the “Last Gift” cohort involving rapid autopsy of
PLWH found persistent HIV
reservoirs crosswise 28 tissues, with multiple sites acting as ‘hubs’ for
dissemination, though blood and lymphoid tissues dollop as the important
sources . There is evidence that multiple tissues, including the CNS and reproductive organs, may be sanctuary
sites for HIV due to their immune-privileged status and the evidence for
secondary lymphoid tissues as a major donor to HIV persistence is unequivocal.
· Rare individuals can commonly control HIV infection by immune-mediated mechanisms.
· HIV cures could be functional or sterilizing.
· Immunotherapies to cure HIV could exploit and boost T-cell and B-cell responses.
· Combination immunotherapies are most likely to succeed in HIV cure.
Comments
Post a Comment